NADIR PSA and time to NADIR PSA after radiotherapy +/- androgen deprivation as a predictor of prostate cancer outcome.

被引：0
|
作者：
Sancho Pardo, G.
GAmez de Segura, G.
Gich, I.
FarrA, N.
Membrive, I.
Trilla, J.
RosellA, A.
机构：
[1] Hosp Santa Creu & Santa Pau, Dept Radiotherapy & Radiat Oncol, Barcelona, Spain
[2] Hosp Santa Creu & Santa Pau, Serv Clin Epidemiol & Publ Hlth, Barcelona, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1106
引用
收藏
页码：S451 / S452
页数：2
相关论文
共 50 条
  • [41] PSA Nadir and Outcome in 100 Patients with pT3b Prostate Cancer
    Pepe, Pietro
    Improta, Giuseppina
    Fraggetta, Filippo
    Emmanuele, Carmela
    Simeon, Vittorio
    Dibenedetto, Giuseppe
    Colecchia, Maurizio
    Aragona, Francesco
    ANTICANCER RESEARCH, 2014, 34 (02) : 937 - 941
  • [42] Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy
    Inci, Bediz Kurt
    Gurler, Fatih
    Sutcuoglu, Osman
    Bastug, Vural
    Yazici, Ozan
    Uner, Aytug
    Ozet, Ahmet
    Ozdemir, Nuriye
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S845 - S850
  • [43] PSA NADIR DURING ANDROGEN DEPRIVATION THERAPY PREDICTS ADVERSE PROSTATE CANCER SPECIFIC OUTCOMES: RESULTS FROM THE SEARCH DATABASE
    Keto, Christopher J.
    Aronson, William J.
    Terris, Martha K.
    Presti, Joseph C.
    Amling, Christopher L.
    Kane, Christopher J.
    Freedland, Stephen J.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E919 - E919
  • [44] PSA KINETICS AFTER HIGH DOSE RATE BRACHYTHERAPY IN PROSTATE CANCER. LONG TIME TO PSA NADIR AND NO FAILURES SEEN FOR PATIENTS WITH PSA BOUNCE.
    Astrom, L.
    Turesson, I.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S338 - S338
  • [45] Outcome after brachytherapy for prostate cancer with disease freedom defined by an undetectable PSA compared with nadir plus 2
    Critz, Frank A.
    Levinson, A. Keith
    Benton, James B.
    Shrake, Philip D.
    Schnell, Frederick J.
    Merlin, Mark
    JOURNAL OF UROLOGY, 2007, 177 (04): : 586 - 587
  • [46] Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP)
    Kitagawa, Yasuhide
    Ueno, Satoru
    Izumi, Kouji
    Mizokami, Atsushi
    Hinotsu, Shiro
    Akaza, Hideyuki
    Namiki, Mikio
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (04) : 673 - 679
  • [47] Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP)
    Yasuhide Kitagawa
    Satoru Ueno
    Kouji Izumi
    Atsushi Mizokami
    Shiro Hinotsu
    Hideyuki Akaza
    Mikio Namiki
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 673 - 679
  • [48] Undetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockade
    Soga, Norihito
    Arima, Kiminobu
    Sugimura, Yoshiki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (09) : 617 - 622
  • [49] PSA nadir ≤4ng/ml within 4 months after External Radiotherapy and Brachytherapy of prostate cancer as a new indicator for outcome
    Nickers, P
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S27 - S27
  • [50] POST-SALVAGE THERAPY, PARTICULARLY WITH NADIR PSA < 1, DELAYS THE TIME TO SUBSEQUENT ANDROGEN DEPRIVATION THERAPY
    Desai, Anuj
    Haseebuddin, Mohammed
    Parker, Daniel
    Devarajan, Karthik
    Waingankar, Nikhil
    Ristau, Benjamin
    Haifler, Michael
    Horwitz, Eric
    Turrisi, Colleen
    Kutikov, Alexander
    Smaldone, Marc
    Greenberg, Richard
    Uzzo, Robert
    Viterbo, Rosalia
    Chen, David
    JOURNAL OF UROLOGY, 2016, 195 (04): : E144 - E144
12345